Allergies Drug Delivery Medicine 
Camargo
NOVEMBER 24, 2020
Most are familiar with, know someone who uses, or take “pumps” themselves to prevent or relieve shortness of breath after an effort or during allergy season. Why is pulmonary drug delivery a complex challenge? How can we accomplish drug delivery to the lungs in nonclinical studies? Author: Nicolay Ferrari, PhD.
The Pharma Data
JANUARY 6, 2021
(“CytoDel” or “the Company”), a privately-held corporation, today announces the publication of preclinical data on the Company’s lead product, Cyto-111, in the peer-reviewed journal, Science Translational Medicine. Cyto-111 was conceived, expressed and purified in the laboratory of Konstantin Ichtchenko, Ph.D., Südhof, M.D., Band, Ph.D.,
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Scienmag
MARCH 28, 2021
Newly-published “contact lens technologies of the future” paper reviews innovative uses for disease detection and therapy, drug delivery, vision enhancement and mor Credit: Centre for Ocular Research & Education (CORE) WATERLOO, Ontario, March 29, 2021–A newly-published paper represents one of the most comprehensive reviews of (..)
The Pharma Data
OCTOBER 14, 2020
15, 2020 /PRNewswire/ — Seattle Gummy Company’s breakthrough gummy drug program, which delivers Active Pharmaceutical Ingredients (APIs) in its innovative gummy matrix, recently won its first Investigational New Drug Application (IND) approval from FDA on the company’s allergy gummy medication, designated as IND 140312.
The Pharma Data
SEPTEMBER 2, 2021
As a global leader in respiratory and allergy, we remain committed to reimagining medicine for patients living with chronic respiratory diseases like asthma.”. The sensor does not alter the drug delivery characteristics of the Breezhaler inhaler itself but produces a recording of each administered dose.
Expert insights. Personalized for you.
130 
Let's personalize your content